Article Versions Notes

Jackson N, Alhussan A, Bromma K, Jay D, Donnelly JC, West FG, Lavasanifar A, Weinfeld M, Beckham W, Chithrani DB. Repurposing Antimalarial Pyronaridine as a DNA Repair Inhibitor to Exploit the Full Potential of Gold-Nanoparticle-Mediated Radiation Response. Pharmaceutics. 2022; 14(12):2795. https://doi.org/10.3390/pharmaceutics14122795

Jackson, Nolan, Abdulaziz Alhussan, Kyle Bromma, David Jay, James C. Donnelly, Frederick G. West, Afsaneh Lavasanifar, Michael Weinfeld, Wayne Beckham, and Devika B. Chithrani. 2022. "Repurposing Antimalarial Pyronaridine as a DNA Repair Inhibitor to Exploit the Full Potential of Gold-Nanoparticle-Mediated Radiation Response" Pharmaceutics 14, no. 12: 2795. https://doi.org/10.3390/pharmaceutics14122795

Jackson, N., Alhussan, A., Bromma, K., Jay, D., Donnelly, J. C., West, F. G., Lavasanifar, A., Weinfeld, M., Beckham, W., & Chithrani, D. B. (2022). Repurposing Antimalarial Pyronaridine as a DNA Repair Inhibitor to Exploit the Full Potential of Gold-Nanoparticle-Mediated Radiation Response. Pharmaceutics, 14(12), 2795. https://doi.org/10.3390/pharmaceutics14122795